Fig. 3.
Treatment-emergent adverse events per 100 patient-years by years of treatment. AE: adverse event; D/C: discontinuation; IXE: ixekizumab; NMSC: non-melanoma skin cancer; PY: patient-years; SAE: serious adverse event
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.